CYTOKINES AND GROWTH-FACTORS IN ENDOTHELIAL DYSFUNCTION

被引:57
作者
LEFER, AM
MA, XL
机构
关键词
ISCHEMIA; MYOCARDIAL; CYTOKINES; TRANSFORMING GROWTH FACTOR-BETA; NEUTROPHILS; MYOCARDIAL DEPRESSANT FACTOR; ENDOTHELIUM; ENDOTHELIUM-DERIVED RELAXING FACTOR; SPLANCHNIC CIRCULATION; TUMOR NECROSIS FACTOR; SUPEROXIDE DISMUTASE; CRITICAL ILLNESS;
D O I
10.1097/00003246-199302001-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this focused review is to call attention to the important interrelationships between growth factors (e.g., transforming growth factor-beta) and cytokines (e.g., tumor necrosis factor [TNF]) on endothelial function as characterized by the ability of the endothelium to release endothelium-derived relaxing factor. Background and Methods: Myocardial ischemia followed by reperfusion leads to a severe degree of endothelial dysfunction characterized by an impaired vasodilator response to endothelial-dependent vasodilators. The reduction in endothelial-dependent responses occurs rapidly after the onset of reperfusion. Endothelial dysfunction was studied in coronary artery as well as superior mesenteric artery rings, and the effects of cytokines, transforming growth factor-beta, and free radicals were assessed. Results: Oxygen-derived free radicals (i.e., superoxide anion) and cytokines (i.e., TNF) contribute to this endothelial dysfunction, which is characterized by a loss of endothelium-derived relaxing factor, now known to be identical to nitric oxide. Agents such as superoxide dismutase or transforming growth factor-beta can significantly preserve endothelial integrity during ischemia-reperfusion states. Conclusions: Endothelial dysfunction is an early and critical phenomenon occurring in ischemia-reperfusion injury both in the coronary and the mesenteric circulations.
引用
收藏
页码:S9 / S14
页数:6
相关论文
共 38 条
  • [1] ANTI-EDRF EFFECT OF TUMOR NECROSIS FACTOR IN ISOLATED, PERFUSED CAT CAROTID ARTERIES
    AOKI, N
    SIEGFRIED, M
    LEFER, AM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (05): : H1509 - H1512
  • [2] BENEFICIAL-EFFECTS OF 2 FORMS OF NO ADMINISTRATION IN FELINE SPLANCHNIC ARTERY-OCCLUSION SHOCK
    AOKI, N
    JOHNSON, G
    LEFER, AM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (02): : G275 - G281
  • [3] NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS
    BAGGIOLINI, M
    WALZ, A
    KUNKEL, SL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) : 1045 - 1049
  • [4] BITTERMAN H, 1988, P SOC EXP BIOL MED, V188, P265
  • [5] BULKLEY GB, 1989, SPLANCHNIC ISCHEMIA, P183
  • [6] ROLE OF LEUKOCYTES IN RESPONSE TO ACUTE MYOCARDIAL-ISCHEMIA AND REFLOW IN DOGS
    ENGLER, RL
    DAHLGREN, MD
    MORRIS, DD
    PETERSON, MA
    SCHMIDSCHONBEIN, GW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (02): : H314 - H323
  • [7] PURIFICATION AND INITIAL CHARACTERIZATION OF A TYPE-BETA TRANSFORMING GROWTH-FACTOR FROM HUMAN-PLACENTA
    FROLIK, CA
    DART, LL
    MEYERS, CA
    SMITH, DM
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3676 - 3680
  • [8] ENDOTHELIUM-DERIVED RELAXING FACTOR INHIBITS INVITRO PLATELET-AGGREGATION
    FURLONG, B
    HENDERSON, AH
    LEWIS, MJ
    SMITH, JA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (04) : 687 - 692
  • [9] ENDOTHELIAL INTERLEUKIN-8 - A NOVEL INHIBITOR OF LEUKOCYTE-ENDOTHELIAL INTERACTIONS
    GIMBRONE, MA
    OBIN, MS
    BROCK, AF
    LUIS, EA
    HASS, PE
    HEBERT, CA
    YIP, YK
    LEUNG, DW
    LOWE, DG
    KOHR, WJ
    DARBONNE, WC
    BECHTOL, KB
    BAKER, JB
    [J]. SCIENCE, 1989, 246 (4937) : 1601 - 1603
  • [10] ROLE OF LYSOSOMES IN PATHOGENESIS OF SPLANCHNIC ISCHEMIA SHOCK IN CATS
    GLENN, TM
    LEFER, AM
    [J]. CIRCULATION RESEARCH, 1970, 27 (05) : 783 - &